# Efficacy and Safety of ZT006 in Overweight and Obese Participants

> **NCT07230132** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Beijing QL Biopharmaceutical Co.,Ltd** · enrollment: 184 (actual)

## Conditions studied

- Overweight , Obesity

## Interventions

- **DRUG:** ZT006
- **DRUG:** Placebo of ZT006

## Key facts

- **NCT ID:** NCT07230132
- **Lead sponsor:** Beijing QL Biopharmaceutical Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-12-12
- **Primary completion:** 2026-12-12
- **Final completion:** 2027-03
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07230132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07230132, "Efficacy and Safety of ZT006 in Overweight and Obese Participants". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07230132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*